Suppr超能文献

定性 [18F]FDG PET/CT 对术后甲状腺球蛋白升高且放射性碘全身扫描阴性的分化型甲状腺癌患者临床结局的预测作用。

The impact of qualitative [18F]FDG PET/CT in predicting clinical outcomes of post-surgical differentiated thyroid cancer patients with elevated thyroglobulin and negative radioiodine whole-body scan.

机构信息

Department of Nuclear Medicine, Tran Hung Dao Hospital (Hospital 108), Hanoi, Vietnam.

出版信息

BMC Surg. 2024 Nov 26;24(1):377. doi: 10.1186/s12893-024-02675-x.

Abstract

BACKGROUND

[F]FDG PET/CT has been widely used as a diagnostic tool in detection and localization of recurrent non-avid radioiodine lesions in post-operative differentiated thyroid cancer (DTC) patients with elevated serum thyroglobulin but negative radioiodine whole-body scan (TENIS) syndrome. The aim of our study was to evaluate the role of [F]FDG PET/CT in prediction on outcomes of these DTC patients.

METHODS

Post-operative DTC patients with TENIS syndrome were collected in the department of nuclear medicine, Hospital 108 from 2019 to 2023. Patients underwent [F]FDG PET/CT with standard protocol following EANM guideline for tumor imaging version 2.0. The qualitative [F]FDG PET/CT imaging characteristics were classified into three categories: (i) negative [F]FDG PET/CT, (ii) minimal [F]FDG PET/CT volume of lesions, (iii) extensive [F]FDG PET/CT volume of lesions. Progression-free survival (PFS) and overall survival (OS) were the end point of the study. The prognosis of qualitative [F]FDG PET/CT in predicting PFS and OS was illustrated by Kaplan-Meier survival analysis. The independent factors predicting PFS and OS were determined by univariate and multivariate analysis using logistic regression.

RESULTS

There were 164 consecutive patients, 51.2% female and 48.8% female. The most common histopathological type was papillary accounting for 91.5%. The median time of follow-up was 33.3 months, (range 6.57 - 82.5). There was 70 (36.6%) progressions and 12 (7.35%) deaths. Negative [F]FDG PET/CT uptake patients had median PFS with median 57.1 months which was higher than that of minimal category (46.2 months), and extensive category (37.6 months) (p < 0,001). 1-year OS and 5-year OS in extensive PET/CT category was 97.8% and 86.2% respectively which were significantly lower than that of negative and minimal categories (p = 0.053). In multivariate analysis, age at the time of diagnosis, pulmonary, bone metastases and extensive [F]FDG PET/CT volume of lesions were the independent factor predicting PFS. Bone metastasis was only the factor could predict OS in multivariate analysis.

CONCLUSIONS

The minimal and negative [F]FDG PET/CT categories had better prognosis than extensive category in PFS and OS. Extensive [F]FDG PET/CT category was an independent factor for predicting PFS. Bone metastasis was only the independent factor that could predict both PFS and OS.

摘要

背景

正电子发射断层扫描(PET)/CT 已广泛用于检测和定位术后分化型甲状腺癌(DTC)患者血清甲状腺球蛋白升高但放射性碘全身扫描(TENIS)阴性的复发性非放射性碘病灶。我们的研究目的是评估[F]FDG PET/CT 在预测这些 DTC 患者结局方面的作用。

方法

2019 年至 2023 年,在核医学科收集了 TENIS 综合征的术后 DTC 患者。患者根据 EANM 肿瘤成像指南版本 2.0 进行标准方案的[F]FDG PET/CT 检查。[F]FDG PET/CT 成像的定性特征分为三类:(i)阴性[F]FDG PET/CT,(ii)病变[F]FDG PET/CT 体积最小,(iii)病变[F]FDG PET/CT 体积广泛。无进展生存期(PFS)和总生存期(OS)是本研究的终点。通过 Kaplan-Meier 生存分析说明定性[F]FDG PET/CT 对 PFS 和 OS 的预后预测。通过单变量和多变量分析使用逻辑回归确定预测 PFS 和 OS 的独立因素。

结果

连续 164 例患者,51.2%为女性,48.8%为女性。最常见的组织病理学类型是乳头状,占 91.5%。中位随访时间为 33.3 个月(范围 6.57-82.5)。有 70 例(36.6%)进展,12 例(7.35%)死亡。阴性[F]FDG PET/CT 摄取患者的中位 PFS 为 57.1 个月,高于最小类别(46.2 个月)和广泛类别(37.6 个月)(p<0.001)。广泛 PET/CT 类别的 1 年 OS 和 5 年 OS 分别为 97.8%和 86.2%,显著低于阴性和最小类别(p=0.053)。多变量分析显示,诊断时年龄、肺、骨转移和广泛[F]FDG PET/CT 病变体积是 PFS 的独立预测因素。骨转移是多变量分析中唯一可预测 OS 的因素。

结论

在 PFS 和 OS 方面,最小和阴性[F]FDG PET/CT 类别比广泛类别具有更好的预后。广泛的[F]FDG PET/CT 类别是预测 PFS 的独立因素。骨转移是唯一可预测 PFS 和 OS 的独立因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a4/11590570/29b351ec0fde/12893_2024_2675_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验